PAD Clinical Trial
Official title:
Study of Peripheral Arterial Calcification as a Possible Predictor of Outcome After Endovascular Therapy
Aim of the work :
1. Using different calcification scoring systems to investigate the association between
arterial calcification and clinical outcome following endovascular therapy
Peripheral arterial disease (PAD) is a worldwide health problem and its prevalence is
increasing among aging population. Symptomatic PAD Is a major cause of major amputation with
reduction of the functional capacity and quality of life . Arterial calcification is calcium
crystallization deposits in the extracellular matrix of the intima and media . Medial
calcification is usually associated with chronic kidney disease and diabetes mellitus, while
intimal calcification comes usually as a part of atherosclerotic process . The relationship
between calcification and PAD is well established . Arterial calcification is associated with
increased risk of procedural failure and major amputation . Many calcium scoring systems have
been proposed, including peripheral arterial calcium scoring scale (PACSS which highlights
the pathologic location of calcification along with the length of the segment affected. The
peripheral academic research consortium (PARC) suggested another calcium scoring scale that
classified calcification into 4 major grades . The DEFENETIVE Ca++ have proposed another
calcium severity scoring . Intravascular Ultrasound (IVUS) is highly sensitive to presence
and location of atherosclerotic calcium .
The impact of intimal and medial vascular calcification on the safety and effectiveness of
endovascular devices to treat symptomatic peripheral arterial disease (PAD) remains poorly
defined warranting continued research to elaborate relationship between calcification and
endovascular outcome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03157531 -
Safety and Effectiveness of B-Laserâ„¢ in Subjects Affected With Infrainguinal PAD
|
N/A | |
Recruiting |
NCT03668353 -
Recombinant SeV-hFGF2/dF Injection for PAOD
|
Phase 1 | |
Completed |
NCT02561299 -
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
|
N/A | |
Completed |
NCT01355406 -
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
|
N/A | |
Recruiting |
NCT06239493 -
IVUS-Guided Treatment for Percutaneous Vascular Interventions
|
||
Active, not recruiting |
NCT00390767 -
Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)
|
Phase 1/Phase 2 | |
Completed |
NCT02907203 -
Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
|
||
Recruiting |
NCT03686228 -
Treatment of No-option CLI by G-CSF-mobilized PB-MNC
|
N/A | |
Recruiting |
NCT03683628 -
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
|
N/A | |
Active, not recruiting |
NCT04204564 -
VISION and VQI Paclitaxel Safety Analysis
|
||
Terminated |
NCT01341340 -
The ABSORB BTK (Below The Knee) Clinical Investigation
|
N/A | |
Completed |
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 | |
Recruiting |
NCT03900832 -
Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability
|
Early Phase 1 | |
Completed |
NCT03452293 -
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
|
||
Recruiting |
NCT05361967 -
Tack Optimized Balloon Angioplasty Post-Market Study
|
||
Active, not recruiting |
NCT02500303 -
Influence of Diabetes on Lower Limb Amputation
|
N/A | |
Completed |
NCT03358355 -
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03516383 -
Pulse Wave Velocity Imaging in the Assessment of PAD
|
||
Completed |
NCT03590769 -
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
|
Phase 1 | |
Completed |
NCT01938391 -
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
|
N/A |